Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Amiodarone monitoring practices in pediatric hospitals in the United States.

Moffett BS, Valdes SO, Kim JJ.

Pediatr Cardiol. 2013;34(8):1762-6. doi: 10.1007/s00246-013-0710-8. Epub 2013 May 3.

PMID:
23640245
2.

Monitoring the use of amiodarone: compliance with guidelines.

Burgess C, Blaikie A, Ingham T, Robinson G, Narasimhan S.

Intern Med J. 2006 May;36(5):289-93.

PMID:
16650193
3.

Adherence to the NASPE guideline for amiodarone monitoring at a medical university.

Bickford CL, Spencer AP.

J Manag Care Pharm. 2006 Apr;12(3):254-9.

4.

Evaluation of a pharmacist-managed amiodarone monitoring program.

Spence MM, Polzin JK, Weisberger CL, Martin JP, Rho JP, Willick GH.

J Manag Care Pharm. 2011 Sep;17(7):513-22.

5.

Evaluating the Safety of Intraoperative Antiarrhythmics in Pediatric Cardiac Surgery Patients.

Beaty RS, Moffett BS, Hall S, Kim J.

Pediatr Cardiol. 2015 Oct;36(7):1465-9. doi: 10.1007/s00246-015-1187-4. Epub 2015 May 17.

PMID:
25981562
6.

Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.

Snider M, Kalbfleisch S, Carnes CA.

Clin Ther. 2009 Jun;31(6):1209-18. doi: 10.1016/j.clinthera.2009.06.014.

PMID:
19695388
7.

The efficacy of amiodarone-propranolol combination for the management of childhood arrhythmias.

Akin A, Karagöz T, Aykan HH, Özer S, Alehan D, Özkutlu S.

Pacing Clin Electrophysiol. 2013 Jun;36(6):727-31. doi: 10.1111/pace.12107. Epub 2013 Feb 25.

PMID:
23438019
8.

[Amiodarone therapy in childhood: efficacy and side effects].

Vignati G, Danzi GB, Austoni P, Fancini P, Mascarello M, Figini A.

G Ital Cardiol. 1985 Aug;15(8):786-94. Italian.

PMID:
2935440
9.

[Treatment with amiodarone].

Adelborg K, Ebbehøj E, Nielsen JC, Grove EL.

Ugeskr Laeger. 2015 Jun 8;177(24):1168-71. Review. Danish.

PMID:
26554056
10.

Adherence to guidelines in monitoring amiodarone-induced thyroid dysfunction.

Huang CJ, Tseng CL, Chu CH, Huang DF, Huang CC, Lin LY.

J Eval Clin Pract. 2017 Feb;23(1):108-113. doi: 10.1111/jep.12619. Epub 2016 Aug 12.

PMID:
27515316
11.

Adherence to amiodarone monitoring recommendations before and after implementation of a centralized pharmacy service: a cohort study.

Johnson SG, Canty K, Billups S, Schimmer J.

J Pharm Pract. 2010 Dec;23(6):536-9. doi: 10.1177/0897190009358770. Epub 2010 Apr 14.

PMID:
21507859
12.

[Amiodarone for long term treatment of arrhythmia in children].

Rokicki W, Durmała J, Nowakowska E.

Wiad Lek. 2001;54(1-2):45-50. Polish.

PMID:
11344701
13.

Effectiveness of Pharmacist-Led Amiodarone Monitoring Services on Improving Adherence to Amiodarone Monitoring Recommendations: A Systematic Review.

Dixon DL, Dunn SP, Kelly MS, McLlarky TR, Brown RE.

Pharmacotherapy. 2016 Feb;36(2):230-6. doi: 10.1002/phar.1697. Epub 2016 Feb 5. Review.

PMID:
26846446
14.

The clinical value of regular thyroid function tests during amiodarone treatment.

Benjamens S, Dullaart RPF, Sluiter WJ, Rienstra M, van Gelder IC, Links TP.

Eur J Endocrinol. 2017 Jul;177(1):9-14. doi: 10.1530/EJE-17-0018. Epub 2017 Apr 19.

PMID:
28424174
15.

Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?

Schwaiblmair M, Berghaus T, Haeckel T, Wagner T, von Scheidt W.

Clin Res Cardiol. 2010 Nov;99(11):693-700. doi: 10.1007/s00392-010-0181-3. Epub 2010 Jul 10. Review.

PMID:
20623129
16.
17.

Amiodarone pulmonary toxicity.

Wolkove N, Baltzan M.

Can Respir J. 2009 Mar-Apr;16(2):43-8. Review.

18.

Amiodarone therapy effects on childhood thyroid function.

Costigan DC, Holland FJ, Daneman D, Hesslein PS, Vogel M, Ellis G.

Pediatrics. 1986 May;77(5):703-8.

PMID:
3703637
19.

Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice.

Stelfox HT, Ahmed SB, Fiskio J, Bates DW.

Clin Pharmacol Ther. 2004 Jan;75(1):110-22.

PMID:
14749697
20.

Rationale, development, and clinical outcomes of a multidisciplinary amiodarone clinic.

Sanoski CA, Schoen MD, Gonzalez RC, Avitall B, Bauman JL.

Pharmacotherapy. 1998 Nov-Dec;18(6 Pt 2):146S-151S.

PMID:
9855347

Supplemental Content

Support Center